Catabasis Pharmaceuticals, Inc. CATB
Set alert
At close
52-week range unavailable
- Open
- 10.07
- Prev close
- 8.54
- Mkt cap
- 109.52M
- Vol
- 98.87K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.48
- High
- 9.21
- Forward P/E
- -2.81
- Beta
- 1.66
- Short ratio
- 0.87
- Inst. own
- 55.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2021
- 50-d avg
- 8.23
- 200-d avg
- 3.74
- 1y target
- 23.00
News
5 years ago benzinga.com
Catabasis Renames As Astria Therapeutics With New Disease Focus
Once-struggling, Catabasis Pharmaceuticals Inc (NASDAQ: CATB) is looking to hit the reset button with a new name and focus. Catabasis has been dragging for several years, weighed down mainly by the…
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 124 companies hit new 52-week highs.
5 years ago pulse2.com
Catabasis Pharmaceuticals Shares: 1-For-6 Split Goes Into Effect
Catabasis Pharmaceuticals Inc (NASDAQ: CATB) deployed a reverse stock split of its shares of common stock at a ratio of 1-for-6. These are the details.
5 years ago seekingalpha.com
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
5 years ago pulse2.com
CATB Stock Price Increases Over 40% Pre-Market: Why It Happened
The stock price of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) increased by over 40% pre-market. This is why it happened.
5 years ago businesswire.com
Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
5 years ago businesswire.com
Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
5 years ago 247wallst.com
AEP, Oracle, Tesla and More Thursday Afternoon Analyst Calls
With the trading day halfway over, the broad markets were making yet another strong push.
5 years ago businesswire.com
Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences.
5 years ago investorplace.com
CATB Stock: Why Catabasis Pharma Stock Is Skyrocketing Today
Catabasis Pharma (CATB) stock is soaring higher on Friday after announcing its acquisition of Quellis Biosciences and a PIPE. The post CATB Stock: Why Catabasis Pharma Stock Is Skyrocketing Today…
5 years ago businesswire.com
Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.
BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that it has acquired Quellis Biosciences Inc. (“Quellis”), a privately-held…
5 years ago investorplace.com
Catabasis Pharmaceuticals: 9 Things for Potential CATB Stock Investors to Know
Catabasis Pharmaceuticals (CATB) stock is taking off on Wednesday despite a lack of news from the biopharmaceutical company. The post Catabasis Pharmaceuticals: 9 Things for Potential CATB Stock…
6 years ago investorplace.com
Catabasis Pharmaceuticals News: Why CATB Stock Is Plummeting 69% Today
Catabasis Pharmaceuticals (CATB) news for Tuesday includes incredibly poor results from a clinical trial hammering CATB stock hard. The post Catabasis Pharmaceuticals News: Why CATB Stock Is…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 127 stocks hit new 52-week highs.
6 years ago businesswire.com
SAB Biotherapeutics annonce le dosage du premier patient de l’essai clinique de phase 1b de SAB-185 pour le traitement du COVID-19
SAB Biotherapeutics announces the first patient dosed in its Phase 1B study evaluating SAB-185, the second study initiated this month for COVID-19.
6 years ago dentistry.co.uk
Dentistry – your ticket around the globe? Part three – Dentistry Online
Thinking of moving abroad? Roshan Bains explores what requirements dentists need to practise elsewhere. In part two, he looks at UAE and Singapore.
6 years ago businesswire.com
SAB Biotherapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of SAB-185 for the Treatment and Prevention of COVID-19
SAB Biotherapeutics (SAB), a clinical stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high
6 years ago businesswire.com
Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress
Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress
6 years ago benzinga.com
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
6 years ago patch.com
Questions; Confusion Regarding Military Medical System
Your kidneys are failing and your doctor has just deployed. Now what?
6 years ago businesswire.com
SAB Biotherapeutics Awarded $35.6M from U.S. Department of Defense for COVID-19 and Scaling Rapid Response Antibody Program
SAB Biotherapeutics awarded $35.6M from U.S. Department of Defense for COVID-19 therapeutic and scaling Rapid Response Antibody Program.
6 years ago wholefoodsmagazine.com
Study: Benefits of Omega-3 on Alzheimer's Patients Reliant on Dose | WholeFoods Magazine
Sioux Falls, SD—Alzheimer’s patients may need higher omega-3 intakes to see benefits than previously thought, according to a study published in The Lancet. The study looked at 33 men and women from…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
-
7 years ago benzinga.com
48 Stocks Moving In Wednesday's Mid-Day Session
48 Stocks Moving In Wednesday's Mid-Day Session
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018
Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, August 2nd
Stocks Which Set New 52-Week Low Yesterday, August 2nd
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, August 1st
Stocks Which Set New 52-Week Low Yesterday, August 1st
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Lows Yesterday:
Stocks Which Set New 52-Week Lows Yesterday:
-
9 years ago benzinga.com
13 Emerging Biotech Companies With Catalysts In 2017
13 Emerging Biotech Companies With Catalysts In 2017